PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Dec-2022 Spinal Osteosynthesis Units Market is projected to grow at a steady CAGR of 4.8% From 2022 – 2032 MARKITWIRED
14-Dec-2022 Cantourage Group SE: Most potent cannabis flower on the German market: Cantourage launches Miracle Valley’s second product Cantourage Group SE
14-Dec-2022 Ellipses Announces First Patient Dosed with EP0031, a Next Generation Selective RET Inhibitor Businesswire
14-Dec-2022 PQE Group and Techniconsult Group: a Strategic Alliance to Provide Strategic Consulting in the Life Science Industry Businesswire
14-Dec-2022 Molecular Diagnostics Market | ABBOTT LABORATORIES, Agilent Technologies Inc., BECTON DICKINSON, BIOMERIEUX SA | By 2032 MARKITWIRED
14-Dec-2022 Nerve Monitoring Devices Market | Medtronic, Dr. Langer Medical GmbH, Magtism, Inomed | By 2032 MARKITWIRED
14-Dec-2022 Top global enterprises and engineers named winners of the inaugural Digital Engineering Awards Businesswire
14-Dec-2022 Clinical Information System Market | Allscipts, Eclinicalworks, GE Health care, NEXTGen | By 2032 MARKITWIRED
14-Dec-2022 Legionnaire Disease Testing Market | Beckman Coulter Inc., Albagaia Ltd., Bio-Rad Laboratories Inc., Abbott Laboratories | By 2032 MARKITWIRED
14-Dec-2022 DNA Synthesis Market is predicted to advance at a CAGR of 7.7% from 2022 to 2032 MARKITWIRED
14-Dec-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
14-Dec-2022 Ribonexus appoints Steven Powell as CEO Andrew Lloyd Associates
14-Dec-2022 Pathology Imaging Systems Market is anticipated to register a CAGR of 10.3% during the forecast period. MARKITWIRED
14-Dec-2022 Dermatology Cryosurgery Units Market is expected to reach US$ 305.7 Million by 2032 MARKITWIRED
14-Dec-2022 ABBOTT AND THE BRAIN INJURY ASSOCIATION OF AMERICA LAUNCH CONCUSSION AWARENESS NOW COALITION; TEAM UP WITH REBEL WILSON TO RAISE AWARENESS ON SERIOUSNESS OF CONCUSSIONS ABBOTT
14-Dec-2022 GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets GSK
14-Dec-2022 JT Group Recognized on CDP’s “Climate Change A List” for the 4th Consecutive Year Businesswire
14-Dec-2022 Apogenix Enrolls First Patients in Pivotal Phase III Trial for the Treatment of Hospitalized COVID-19 Patients with Asunercept Apogenix AG
14-Dec-2022 Cancellation of remaining publicly held registered shares of Vifor Pharma AG Businesswire
14-Dec-2022 Etcembly Announces Breakthrough in Optimising TCR Assets Etcembly